Which of the following process does NOT contribute to conversion of a proto-oncogene to oncogene?
1. de-activating mutation in tumor suppressor
2. activating mutation in proto-oncogene
3. increased expression of proto-oncogene
4. de-activating mutation in proto-oncogene

 

---

Detailed Explanation:

The correct answer is: 4. de-activating mutation in proto-oncogene

What are Proto-Oncogenes and Oncogenes?

Proto-oncogenes are normal genes involved in regulating cell growth and differentiation. However, when these genes undergo specific mutations or alterations, they can be converted into oncogenes, which can drive the uncontrolled cell growth and division that leads to cancer.

Key Processes Contributing to the Conversion of Proto-Oncogenes to Oncogenes:

1. Activating Mutation in Proto-Oncogene: One of the most common ways proto-oncogenes convert into oncogenes is through an activating mutation. This mutation often results in a gain-of-function in the gene, leading to overactive proteins that drive excessive cell proliferation. Such mutations can be in various forms, such as point mutations or insertions that lead to a constitutively active protein.

2. Increased Expression of Proto-Oncogene: Another mechanism by which proto-oncogenes can be converted into oncogenes is through increased expression. This can occur due to gene amplification or increased promoter activity, which results in the overproduction of proteins that stimulate cell division and growth.

3. De-activating Mutation in Tumor Suppressor Genes: While this mutation does not directly affect proto-oncogenes, it can contribute indirectly to the oncogene activation process. De-activating mutations in tumor suppressor genes (like TP53 or RB1) can remove the regulatory brakes on cell division. This allows oncogenes to exert their effects unchecked, thereby facilitating tumor formation.

4. De-activating Mutation in Proto-Oncogene: A de-activating mutation in a proto-oncogene would typically lead to a loss-of-function mutation, which does not contribute to the conversion of proto-oncogenes into oncogenes. Such mutations usually result in the inactivation of the gene, potentially leading to the loss of cell growth promotion, rather than causing uncontrolled cell division associated with oncogene activation.

Why De-Activating Mutation in Proto-Oncogene Does Not Lead to Oncogene Formation:

Proto-oncogenes normally function to regulate cell growth. A de-activating mutation in these genes would likely reduce their ability to stimulate cell division, preventing the overgrowth characteristic of oncogenes. Thus, this type of mutation does not contribute to the conversion of proto-oncogenes to oncogenes and would not be considered a driver of cancer.

Conclusion:

In summary, the processes that lead to the conversion of proto-oncogenes to oncogenes typically involve activating mutations, increased gene expression, and deactivation of tumor suppressors. However, a de-activating mutation in a proto-oncogene would not contribute to the formation of an oncogene and is not a mechanism for cancer development.